Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-3%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$44.4B
AUM Growth
+$1.2B
(+2.8%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281
Top Buys
| 1 |
Broadcom
AVGO
|
+$410M |
| 2 |
Salesforce
CRM
|
+$397M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$351M |
| 4 |
Boston Scientific
BSX
|
+$348M |
| 5 |
Intuitive Surgical
ISRG
|
+$286M |
Top Sells
| 1 |
Visa
V
|
+$575M |
| 2 |
Eli Lilly
LLY
|
+$532M |
| 3 |
Meta Platforms (Facebook)
META
|
+$386M |
| 4 |
Progressive
PGR
|
+$357M |
| 5 |
Lam Research
LRCX
|
+$271M |
Sector Composition
| 1 | Technology | 25.88% |
| 2 | Healthcare | 15.37% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
WisdomTree Japan Hedged Equity Fund
DXJ
$3.82B
| $1.4M | ﹤0.01% |
12,700
-11,700
| -48% | -$1.29M |
|
1302
A.O. Smith
AOS
$10.2B
| $1.4M | ﹤0.01% |
21,400
-18,600
| -47% | -$1.22M |
|
1303
Smith & Wesson
SWBI
$414M
| $1.39M | ﹤0.01% |
+149,600
| New | +$1.39M |
|
1304
Amalgamated Financial
AMAL
$859M
| $1.39M | ﹤0.01% |
48,300
-3,000
| -6% | -$86.3K |
|
1305
Murphy Oil
MUR
$3.68B
| $1.39M | ﹤0.01% |
48,800
-142,900
| -75% | -$4.06M |
|
1306
Castle Biosciences
CSTL
$621M
| $1.39M | ﹤0.01% |
69,200
+57,700
| +502% | +$1.16M |
|
1307
Mercer International
MERC
$206M
| $1.38M | ﹤0.01% |
225,041
+61,100
| +37% | +$376K |
|
|
SFD
1308
Smithfield Foods, Inc. Common Stock
SFD
$9.6B
| $1.38M | ﹤0.01% |
+67,800
| New | +$1.38M |
|
|
CLDT
1309
Chatham Lodging
CLDT
$348M
| $1.38M | ﹤0.01% |
193,853
+42,700
| +28% | +$304K |
|
1310
Collegium Pharmaceutical
COLL
$1.18B
| $1.38M | ﹤0.01% |
46,300
-25,700
| -36% | -$767K |
|
1311
Zai Lab
ZLAB
$3.61B
| $1.38M | ﹤0.01% |
38,200
+20,000
| +110% | +$723K |
|
1312
Stifel
SF
$11.8B
| $1.38M | ﹤0.01% |
14,638
-5,500
| -27% | -$518K |
|
1313
Civeo
CVEO
$287M
| $1.38M | ﹤0.01% |
59,966
-11,100
| -16% | -$255K |
|
1314
1st Source
SRCE
$1.55B
| $1.38M | ﹤0.01% |
23,050
+6,500
| +39% | +$389K |
|
1315
Gannett
GCI
$620M
| $1.38M | ﹤0.01% |
476,356
-30,600
| -6% | -$88.4K |
|
1316
Caribou Biosciences
CRBU
$168M
| $1.38M | ﹤0.01% |
1,507,200
+36,500
| +2% | +$33.3K |
|
1317
NB Bancorp
NBBK
$737M
| $1.37M | ﹤0.01% |
75,900
+38,500
| +103% | +$696K |
|
1318
Matthews International
MATW
$763M
| $1.37M | ﹤0.01% |
61,600
-78,700
| -56% | -$1.75M |
|
1319
TORM
TRMD
$2.21B
| $1.37M | ﹤0.01% |
83,100
-757,900
| -90% | -$12.5M |
|
|
GMRE
1320
Global Medical REIT
GMRE
$512M
| $1.37M | ﹤0.01% |
156,400
-10,900
| -7% | -$95.4K |
|
1321
Cousins Properties
CUZ
$4.94B
| $1.36M | ﹤0.01% |
46,202
-198,877
| -81% | -$5.87M |
|
1322
Cassava Sciences
SAVA
$102M
| $1.36M | ﹤0.01% |
908,600
+301,900
| +50% | +$453K |
|
1323
Vital Energy
VTLE
$635M
| $1.36M | ﹤0.01% |
64,163
-126,900
| -66% | -$2.69M |
|
1324
MacroGenics
MGNX
$100M
| $1.36M | ﹤0.01% |
1,068,200
-50,400
| -5% | -$64K |
|
1325
Dow Inc
DOW
$17.7B
| $1.35M | ﹤0.01% |
+38,800
| New | +$1.35M |
|